Kogi people aren’t guinea pigs, We won’t take the COVID-19 Governor Yahaya Bello

As Nigeria commenced its vaccination against the lethal coronavirus infection on Friday, Kogi State Governor, Yahaya Bello, in a Channels TV program, Sunrise Daily, has said he won’t receive the vaccine even as his colleagues are expected to receive shots of the AstraZeneca/Oxford COVID-19 vaccines in the coming days.

“COVID-19 is not our business in Kogi State. We have more pertinent issues and more pertinent matters that we are attending to in Kogi State. Insecurity we met, we’ve tackled it and several others. Disunity we met on ground and we have united Kogi State today not COVID-19.

“COVID-19 is just a minute aspect of what we are treating or handling in Kogi State…If the Federal Government is gracious enough and give us COVID-19 vaccines, we will equally sensitise our people, people who wish to come and take can come and take but I am not going to subject the people of Kogi State to vaccines or vaccination and I will not make them the guinea pigs,” he said.


President Of Nigeria Buhari And His Vice President Osinbajo Will Pick Date For Their Covid-19 Vaccination

President Muhammadu Buhari and Vice President, Yemi Osinbajo will pick dates on which they will be vaccinated publicly, with the first batch of Oxford/AstraZeneca COVID-19 vaccine, which is about four million doses, expected to arrive in Nigeria on Tuesday.

The Executive Director, National Primary Health Care Development Agency (NPHCDA), Dr. Faisal Shuaib, disclosed this at the Presidential Taskforce on COVID-19 briefing on Monday in Abuja.

Shuaib said that the Secretary to the Government of the Federation and chairman of the PTF on COVID-19, Mr. Boss Mustapha, would liaise with other key strategic persons to fix the date for the public vaccination aimed at protecting Nigerians against the COVID-19 pandemic.

Shuaib said: “I once again assure Nigerians that all necessary safety and quality control measures have been put in place for the arrival, storage and successful administration of the vaccine in the country. There is going to be a small ceremony, chaired by the Chairman of the PTF on COVID-19, to receive the vaccine at the VIP Protocol section, General Aviation Terminal of Nnamdi Azikiwe International Airport, Abuja.

“At the end of the ceremonies to mark the arrival of the vaccines, a few vials of the vaccines would be handed over to the NAFDAC team fo analysis over a period of two days (Wednesday March 3rd and Thursday March 4th).

“Further to the clearance by NAFDAC, the PTF, FMOH, NPHCDA and strategic leaders will be at the treatment center of the National Hospital on Friday March 5th 2021, where the first vaccination site will be set up to commence the vaccination of the frontline health workers and support staff. These Staff would also be electronically registered in the COVID-19 vaccine database and would receive their COVID-19 vaccination card which has a QR code that can be verified worldwide.

On Saturday, March 6th, Key Strategic leaders will receive the first dose of the vaccine.

“On Monday, March 8th, 2021, more vaccination sites would have been set up at designated locations such as National Assembly clinic, State House clinic and Federal medical centre, Jabi, where strategic leaders such as the SGF, Senate President, Speaker of the House of Representatives, Attorney General of the Federation, Inspector General of Police, the Ministers and Ministers of States, Senators, House of Representatives, traditional leaders and religious leaders would be vaccinated.


Ivory Coast receives COVAX COVID-19 vaccines

The WHO regional director, Matshidiso Moeti, said the vaccines will be rolled out to frontline health workers in the coming days.

Ivory Coast has received over 500,000 doses of the Oxford-Astrazeneca COVID-19 vaccine through the COVID-19 Vaccines Global Assess Facility (COVAX) making it the second country to benefit from the facility.

Ghana is the first country to benefit from the programme with the delivery of 600,000 doses of the AstraZeneca vaccines on Wednesday.

COVAX, a World Health Organization-backed programme, was set-up to divide about two billion doses of vaccines across 92 low-and middle-income countries.

The facility promised access to vaccines for up to 20 per cent of participating countries’ population with an initial supply beginning in the first quarter of the year to immunise three per cent of their populations.

“Cote d’Ivoire is the second country in Africa to receive COVID-19 vaccines from the COVAX facility,” the World Health Organisation (WHO) regional office for Africa tweeted on Friday.

“504,000 doses of Oxford-AstraZeneca vaccine just arrived in Abidjan. Another step towards #VaccinEquity and a symbol of global cooperation and solidarity.”

The WHO regional director, Matshidiso Moeti, said the vaccines will be rolled out to frontline health workers in the coming days.

“Over half a million vaccines just arrived in Abidjan and will be rolled out with frontline health workers in the coming days,” she said.

Entertainment, Health

Jakande’s Son Recounts His Father’s Last Moments

Deji Jakande, son of the late veteran journalist and politician, Alhaji Lateef Jakande has recounted the last moments of his father.

Deji, a former House of Representatives member, said his father showed no sign of illness in the last 24 hours.

In fact, Jakande, fondly called Baba Kekere by admirers, revalidated his membership of the ruling All Progressives Congress (APC) on Wednesday.

Deji said, “We thank God for his life. He was not sick. He took his pap and crayfish yesterday. He was still reading his newspapers without glasses.

“We had stopped visitors from going to him because of COVID-19 because he likes shaking people. Today (yesterday), he was about to take his breakfast. Suddenly, he couldn’t breathe again. We called the doctor to come and examine him. That was between 10.30 am and

“Many people have been calling. The Governor, the deputy governor, the party chairman had called.

“He will be buried tomorrow after Jumat Service before 4pm at the Vaults and Gardens, Ikoyi.”

Jakande was elected Governor in 1979 on the platform of the defunct Unity Party of Nigeria (UPN) led by the late Chief Obafemi Awolowo.

He was re-elected in 1983 general elections.

He also served as Minister of Works and Housing under the Abacha regime.

He died at age 91.


Covid-19: Failure to wear face mask is punishable with a year jail sentence- Sowolu

The state government has urged residents to comply with COVID-19 guidelines.

The Lagos government has warned residents that violations of the state’s COVID-19 regulations could land them in prison.

After months of recording low figures on a daily basis, Nigeria’s COVID-19 cases have spiked in December with over 11,000 infections detected by the Nigeria Centre for Disease Control (NCDC) in three weeks.


Minister for Health announces the allocation strategy for COVID-19 vaccines

Minister for Health, Stephen Donnelly TD, has today announced the allocation strategy for COVID-19 vaccines, following sign-off from Cabinet.

The strategy prioritises those over the age of 65 living in long-term care facilities, frontline healthcare workers who are in direct patient contact and those aged 70 and over.
The Minister also announced that there should be no barrier to people accessing a vaccine, and therefore the vaccine programme will be available free of charge to everyone in Ireland.
The COVID-19 Vaccine Allocation Strategy was based on a Department of Health and National Immunisation Advisory Committee (NIAC) paper. It sets out a provisional priority list of groups for vaccination once a safe and effective vaccine(s) has received authorisation from the European Medicines Agency (EMA). This paper was endorsed by the National Public Health Emergency Team (NPHET) on 3 December.

The Minister for Health said: “Recent news from vaccine developers are a beacon of hope after a very difficult year. Vaccination is a hugely effective intervention for saving lives and promoting good health. Of course, the safety and effectiveness of vaccines is our absolute priority and any COVID-19 vaccine administered in Ireland will have to be authorised by the European Medicines Agency. While we await news on whether these vaccines comply with all of the EMA’s requirements of quality, safety and efficacy, the Government has been working ahead on plans for the roll-out of vaccines.”
“A key part of the roll-out will be ensuring that those most vulnerable to COVID-19 receive vaccinations first. Given the country’s experience with COVID-19 to date and the risks that vulnerable people and those in frontline roles in the health and social care services continue to face, it is only right that they are prioritised in the allocation of vaccines. The government has followed the advice from our leading medical experts.”
Though Ireland has secured large number of doses of candidate vaccines, the initial availability will be limited if authorised for use, therefore a prioritisation strategy had to be developed.
The COVID-19 Vaccine Allocation Strategy prioritises groups based on (1) ethical principles and (2) epidemiological considerations, and takes account of the current distinctive characteristics of the COVID-19 disease, its modes of transmission, the groups and individuals most susceptible to infection and what is currently known about the candidate vaccines. The Strategy will evolve and adapt with more detailed information on the vaccines and their effectiveness.
The Minister advised that the continued adherence to public health measures is critical to keeping the disease at bay. We will still need to protect each other by continuing to wash our hands, cover our sneezes, avoid crowded places, physically distance, and wear face coverings.

He said: “While some may be tempted to let their guards down now that there are vaccines on the horizon, it is crucially important to continue to follow the public health guidance. COVID-19 is still a deadly disease. Through so much hard work and sacrifice, we now have the lowest 14-day incidence rate of COVID-19 in the EU. We are in a good position, and we want to keep it like that. Please remember that every single contact counts.”


Staying in a toxic relationship can damage your well-being.

A toxic relationship is one that rids you of your peace of mind. Relationships like that take a great toll on your health. They tend to affect not only your mental but also your social well-being.

Even though you might not want to leave such relationships, they are really bad for you. You might feel sound physically, but when emotionally, you are imbalanced, then in truth, you cannot be described as healthy. So seek out a counselor; take a break if you need to, but don’t make it a habit of staying in toxic relationships.


All you need to know about the 42 Anti-malaria Drugs banned in Europe, but that are being consumed in Nigeria-Senate Alleges

The Senate has raised alarm on the alleged circulation of 42 anti-malaria drugs that have been banned in Europe but are being administered and sold to Nigerians in some hospitals and pharmacies. During plenary yesterday, the senate ordered its committee on Health (Secondary and Tertiary), led by Senator Olarewaju Tejuoso, to urgently carry out an indepth investigation into the allegation and report back for further action. The Senate resolution came after a motion by Senator Theodore Orji, was read on the floor of the house.

Orji in his motion said “The Senate notes that recently the European Union banned the sale and consumption of 42 Anti-Malaria Drugs in all countries within the European Union. It notes that the 42 Anti-Malaria Drugs are:

Alaxin 60mg tablet (dihydroartémisinine)B/8;

Alaxin oral suspension (dihydroartémisinine) FL/80ml;

Amodiaquine 200mg compressed B/1000;

Amodiaquine 200mg compressed B/1000;

Arinate 100mg tablet (artésunate) B/6;

Arinate 50mg tablet (artésunate) B/6;

Arsumax 50mg tablet (artésunate) B/12;

Artemax 60mg tablet (dihydroartémisinine) B/8;

Artémédine 40mg capsule (artemether) B/12;

Artémédine 50mg tablet (artemether) B/12;

Artenam 50mg tablet (artemether) B/14

Artenam 60mg tablet (artemether) B/8;

Artésiane 300mg child powder oral suspension (artemether) FL/38g;

Artésunate 100mg compressed B/120;

Artésunate 50mg tablet B/120;

Artexin 60mg tablet (dihydroartémisinine) B/8;

Camoquin 200mg tablet (amodiaquine) B/9;

Camoquin 200mg tablet (amodiaquine) B/25 blisters;

Camoquin 200mg tablet (amodiaquine) B/55 blisters;

Camoquin 200mg tablet (amodiquine) B/24;

Camoquin 600 mg tablet (amodiaquine) B/3;

Camoquin oral suspension 50mg/ 5ml (amodiaquine) FL/60ml;

Cotecxin oral suspension (dihydroartémisinine) FL/80ml;

Cotecxin 60mg tablet (dihydroartémisinine) B/8;

Daraprim tablet (pyriméthamine) B/30;

and Falcinil 50mg tablet (artésunate) B/12.


Covid-19: Corona virus vaccine tested successfully on Humans in Russia

Russia’s Sechenov University Successfully Completes Trials of World’s 1st COVID-19 Vaccine

The clinical trials of the world’s first coronavirus vaccine on volunteers at the Sechenov First Moscow State Medical University have been successfully completed, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, told Sputnik.

The university began clinical trials of a vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on 18 June.

“Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus”, Tarasov said.

He added that the first group of volunteers would be discharged on Wednesday and the second on 20 July.

According to Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical, and Vector-Borne Diseases at Sechenov University, the objective of this stage of the study was to show the vaccine’s safety on humans, which was successfully done.

“The safety of the vaccine has been confirmed. It corresponds to the safety of those vaccines that are currently on the market”, Lukashev told Sputnik.

A further vaccine development plan is already being determined by the developer, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production, Lukashev added.

“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research centre that is able to participate in the creation of such important and complex products as drugs.

We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway”, Tarasov noted